Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?
出版年份 2015 全文链接
标题
Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?
作者
关键词
Infliximab, Etanercept, Adalimumab, Tocilizumab, Abatacept
出版物
ARTHRITIS RESEARCH & THERAPY
Volume 17, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-07-15
DOI
10.1186/s13075-015-0707-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial
- (2014) J L Nam et al. ANNALS OF THE RHEUMATIC DISEASES
- Early start and stop of biologics: has the time come?
- (2014) Ronald F van Vollenhoven et al. BMC Medicine
- One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
- (2014) M. C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)
- (2013) J L Nam et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
- (2013) Josef S Smolen et al. LANCET
- Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study
- (2013) Norihiro Nishimoto et al. Modern Rheumatology
- How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy
- (2013) Georg Schett et al. NATURE MEDICINE
- Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study
- (2012) Jacqueline Detert et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials
- (2012) Karim Raza et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies
- (2012) D. van der Woude et al. RHEUMATOLOGY
- The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study
- (2011) N. B. Klarenbeek et al. ANNALS OF THE RHEUMATIC DISEASES
- Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study
- (2011) M. van den Broek et al. ANNALS OF THE RHEUMATIC DISEASES
- Drug-free remission: is it already possible?
- (2011) Marianne van den Broek et al. CURRENT OPINION IN RHEUMATOLOGY
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating rheumatoid arthritis to target: recommendations of an international task force
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study
- (2010) Y. Tanaka et al. ANNALS OF THE RHEUMATIC DISEASES
- Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: Results from two large early arthritis cohorts
- (2009) Diane van der Woude et al. ARTHRITIS AND RHEUMATISM
- Rheumatoid arthritis
- (2009) Lars Klareskog et al. LANCET
- Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial
- (2009) M. Soubrier et al. RHEUMATOLOGY
- Rheumatoid arthritis and smoking: putting the pieces together
- (2009) Zsuzsanna Baka et al. ARTHRITIS RESEARCH & THERAPY
- Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis
- (2008) S M van der Kooij et al. ANNALS OF THE RHEUMATIC DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started